Warby Parker: The Path to $2B
JAND, Inc., doing business as Warby Parker, began with a mission to provide prescription eyewear at an affordable price while operating a socially conscious business. The company is seeking to raise $75 million in its Series E round of financing. Co-Founder and Co-CEO, Dave Gilboa, has hinted at an eventual IPO in future, however, he claims that company is in no rush to go public. With a valuation nearing $2B, Warby Parker has firmly situated itself as both an indie darling and a tech unicorn.
Warby Parker: The Path to $2B

Calculations are based on shares outstanding. Explain

Companies analyzed in the Path to IPO are chosen on the basis of interest to the investing public and are not necessarily those in which transactions have been completed on the EquityZen platform. An investment through EquityZen is not an investment in a primary funding round; accordingly it is unlikely that an investment through EquityZen will perform similarly to the primary funding rounds highlighted in the Path to IPO. Most private companies are not successful enough to have an IPO, and many successful private companies may elect to not have an IPO. Investing in a private company through EquityZen may result in a partial or complete loss of your investment.

Have questions?